Related Experiment Videos
Ultrahigh resolution optical coherence tomography in macular dystrophy.
Matthias G Wirtitsch1, Erdem Ergun, Boris Hermann
1Department of Ophthalmology, Medical University of Vienna, Währinger Strasse 13, 1090 Vienna, Austria.
American Journal of Ophthalmology
|December 27, 2005
Summary
Ultrahigh resolution optical coherence tomography (UHR OCT) effectively visualizes intraretinal changes in macular dystrophies. This advanced imaging can detect photoreceptor atrophy and monitor disease progression in conditions like Stargardt's disease.
Area of Science:
- Ophthalmology
- Medical Imaging
- Retinal Diseases
Background:
- Macular dystrophies encompass a group of inherited retinal diseases affecting central vision.
- Accurate visualization of intraretinal changes is crucial for diagnosis and management.
Purpose of the Study:
- To utilize ultrahigh resolution optical coherence tomography (UHR OCT) for visualizing and investigating intraretinal alterations in macular dystrophies.
- To compare the morphological differences in adult-onset foveomacular vitelliform dystrophy (AOFVD) and Stargardt's disease (SD)/fundus flavimaculatus (FF) using UHR OCT.
Main Methods:
- A prospective observational case series involving patients with AOFVD and SD/FF.
- Imaging was performed using a new generation UHR OCT system for enhanced visualization of intraretinal layers, particularly the photoreceptor layer.
- Key outcome measures included UHR OCT tomograms detailing deposits, photoreceptor loss, and central foveal thickness.
Main Results:
- Patients with AOFVD exhibited a largely intact photoreceptor layer and subretinal deposits, with a mean central foveal thickness of 142 ± 23 microm.
- Patients with SD showed diffuse degeneration, reduced intraretinal thickness, and central photoreceptor loss, with a mean central foveal thickness of 94 ± 38 microm.
- Significant differences in central foveal thickness were observed between AOFVD and SD/FF groups (P < .001). Fundus flavimaculatus cases presented with pigment epithelial deposits and paracentral photoreceptor loss.
Conclusions:
- UHR OCT is a clinically viable tool for assessing intraretinal changes in macular dystrophies.
- The technology demonstrates potential for visualizing and monitoring photoreceptor atrophy, a key feature of these diseases.
- UHR OCT may serve as an adequate imaging system for tracking disease progression.